Dyslipidemia Patho Flashcards
1
Q
Dyslipidemia
A
- Increase LDL-C, VLDL-C, Triglycerides
- Decrease in HDL-C
2
Q
Dyslipidemia Primary Prevention
A
Prevention of atherosclerotic cardiovascular disease (ASCVD) in a person without a known history of disease
3
Q
Dyslipidemia Secondary Prevention
A
Prevention of ASCVD in a person with a history of ASCVD
4
Q
Modifiable CVD Risks
A
- Physical inactivity
- High blood pressure
- Smoking
- High cholesterol/lipids
- Obesity
- Diabetes mellitus
- Metabolic syndrome
Risk factors are additive
5
Q
Non-Modifiable CVD Risks
A
- Age
- Family history
- Not being female
Risk factors are additive
6
Q
Lipoproteins
A
- High MW and water-soluble, responsible for cholesterol and TG transport
- Chylomicrons, VLDL, IDL, LDL, HDL, and Lp(a)
- Surface is made up of polar, hydrophilic constituents integrated between phospholipid monolayer
- Inner core contains nonpolar hydrophobic lipids, CEs, and TGs
7
Q
Cholesterol
A
- Necessary component of cell membranes, steroid hormones, and bile acid
- Regulated by absorption (extrinsic) and hepatic production/hepatic and bile acid excretion (intrinsic)
- Synthesis accounts for the majority of cholesterol in the body (greatest in liver and intestinal mucosal cells)
8
Q
Major Plasma Lipids
A
- Cholesterol
- Triglycerides
- Phospholipids
9
Q
Phospholipids
A
- Essential for cell function and lipid transport
- Do not directly contribute to atherosclerosis
- Lecithin is the major phospholipid
- Amphophilic and essential in transport of hydrophobic cholesterol esters (CE) and TGs through the plasma
10
Q
Triglycerides
A
- Dietary TGs absorbed as monoglycerides and FFAs
- TGs are formed in liver and transported to adipose tissue for storage
- TG lipolysis releases FFAs allowing for utilization by tissues
11
Q
Exogenous Pathway
A
- Dietary fats are incorporated into chylomicrons from the intestine into circulation to move the fats to adipose tissue
- CMs contain ApoCII that activates lipoprotein lipase which releases TG
- TGs then form FFAs which deposit in muscle and adipose tissue for use
- CM fragments are removed by the liver and recycled
- Cholesterol bile acids promotes lipid emulsification and intestinal absorption
12
Q
Endogenous Pathway (VLDL)
A
- Liver transports TGs (from FAs via the liver or adipose) and some cholesterol
- VLDLs contain ApoCII which performs the same function as in the exogenous pathway
- IDL lose more TG and become LDL
13
Q
LDL
A
- Major cholesterol carrier
- Major lipoprotein: ApoB-100
- CHD risk increases exponentially with increases total and LDL cholesterol
- LDL enters cells by receptor-mediated endocytosis, their hydrolysis in lysosomes releases the free cholesterol
- Number of LDL receptors adjusts cholesterol concentrations for cells (new, developing cells require more)
14
Q
Formation of LDL
A
- Liver produces VLDL
- VLDL then interacts with lipoprotein lipase and becomes a VLDL remnant
- VLDL remnant then interacts with hepatic lipase and becomes LDL
15
Q
Cholesterol Metabolism
A
- LDLs are taken up by endocytosis
- Lysosomes release free cholesterol
- Cholesterol is then esterified by ACAT and stored